Marketing & Strategy
Consumer watchdog to impose hefty penalties on companies and social media influencers

Marketing & Strategy: The Australian Competition and Consumer Commission (ACCC) conducted an extensive internet ‘sweep’ targeting influencer accounts across major platforms including Instagram, TikTok, Snapchat, YouTube, Facebook, and Twitch.
Focusing on seven sectors, including healthcare, the ACCC invited consumers, businesses, and industry participants to report instances of misleading conduct by influencers. A staggering 150 tip-offs were received prior to the sweep, primarily related to influencers failing to disclose commercial relationships in their posts.
Under the Australian Consumer Law (ACL), embedded within the Australian Competition and Consumer Act 2010, businesses, including social media influencers, are prohibited from misleading or deceiving consumers.
The ACCC identified various forms of misleading conduct in influencer marketing, such as:
- Non-disclosure of brand relationships in social media posts.
- Vague or confusing disclosure of brand relationships using terms like ‘sp,’ ‘spon,’ ‘sponcon,’ ‘collab,’ ‘creativepartner,’ ‘ambassador,’ and similar abbreviations.
- False or inaccurate statements about brands, products, or services.
- Other concerning conduct such as multi-level marketing schemes and subscription traps.
The report released last month showed the ACCC is concerned that “this conduct is becoming more pervasive over time as the influencer industry continues to grow”.
To address these concerns, the ACCC proposes a multi-faceted approach involving education, compliance, and enforcement activities. The commission will also release updated guidance material for influencers, brands, and advertisers.
Warning of potential enforcement actions, the ACCC emphasised the importance of compliance with the law. Breaches of the ACL can result in significant penalties, and brands found guilty of misleading or deceiving consumers may suffer severe reputational damage. Social media influencers and brands are advised to ensure their advertising, marketing, and promotional activities align fully with legal standards, particularly in the examined sectors.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals

Clinicians call for closer monitoring of patients post CAR T therapy
Australian clinicians are raising questions about whether cancer patients need closer monitoring after receiving CAR T-cell therapy. A Peter MacCallum […]
MoreNews & Trends - MedTech & Diagnostics

Next-gen surgical mesh to fill critical gap after regulatory ban
Next-generation urogynaecological surgical mesh implants are on the horizon for women suffering from pelvic organ prolapse (POP). This development aims […]
MoreNews & Trends - Pharmaceuticals

Contraceptive lawsuit against Bayer fails
The Victorian Supreme Court has dismissed a class action against Bayer for an allegedly defective contraceptive device. Justice Andrew Keogh […]
MoreNews & Trends - Pharmaceuticals

NSW Government ignored warnings since 2018: Mental health system unravels as psychiatrists quit en masse
The New South Wales Labor government’s plan to “redesign” the state’s mental health system, while excluding psychiatrists, has sparked intense […]
More